Pharmacokinetics of docetaxel, doxorubicin, and cyclophosphamide in combination treatment

被引：0
|
作者：
Cirillo, I
Reyno, L
Gelmon, K
机构：
[1] Aventis Pharmaceut, Bridgewater, NJ USA
[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 44卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
17
引用
收藏
页码：1189 / 1189
页数：1
相关论文
共 50 条
  • [1] Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
    Brown, Taurean
    McElroy, Taylor
    Simmons, Pilar
    Walters, Huddoy
    Ntagwabira, Fabio
    Wang, Jing
    Byrum, Stephanie D.
    Allen, Antino R.
    BRAIN RESEARCH, 2021, 1760
  • [2] Docetaxel in combination with doxorubicin or vinorelbine
    Dieras, V
    Fumoleau, P
    Kalla, S
    Misset, JL
    Azli, N
    Pouillart, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : S20 - S22
  • [3] New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide
    van Boxtel, W.
    Bulten, B. F.
    Mavinkurve-Groothuis, A. M. C.
    Bellersen, L.
    Mandigers, C. M. P. W.
    Joosten, L. A. B.
    Kapusta, L.
    de Geus-Oei, L. F.
    van Laarhoven, H. W. M.
    BIOMARKERS, 2015, 20 (02) : 143 - 148
  • [4] Adjuvant sequential docetaxel and cyclophosphamide-doxorubicin combination in operable breast cancer patients.
    Coskun, HS
    Er, O
    Ozkan, M
    Eser, B
    Altinbas, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 82S - 82S
  • [5] Cyclophosphamide/docetaxel/doxorubicin liposomalCardiotoxicity: 3 case reports
    Reactions Weekly, 2021, 1838 (1) : 167 - 167
  • [6] Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancer
    Martin, Miguel
    WOMENS HEALTH, 2006, 2 (04) : 527 - 537
  • [7] Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer
    Vriens, B. E. P. J.
    Aarts, M. J. B.
    de Vries, B.
    van Gastel, S. M.
    Wals, J.
    Smilde, T. J.
    van Warmerdam, L. J. C.
    de Boer, M.
    van Spronsen, D. J.
    Borm, G. F.
    Tjan-Heijnen, V. C. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (15) : 3102 - 3110
  • [8] Cyclophosphamide/docetaxel/doxorubicin/trastuzumabLymphoedema (first report for cyclophosphamide and trastuzumab): case report
    Reactions Weekly, 2011, 1361 (1) : 16 - 16
  • [9] PHARMACOKINETICS OF INTRAPERITONEAL DOXORUBICIN IN COMBINATION WITH SYSTEMIC CYCLOPHOSPHAMIDE AND CIS-PLATINUM IN THE TREATMENT OF STAGE-III OVARIAN-CANCER
    MALVIYA, VK
    DEPPE, G
    BOIKE, G
    YOUNG, J
    GYNECOLOGIC ONCOLOGY, 1990, 36 (02) : 185 - 188
  • [10] The pharmacokinetics of epirubicin and docetaxel in combination in rats
    Sandström, M
    Simonsen, LE
    Freijs, A
    Karlsson, MO
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (06) : 469 - 474
12345